Kirkland Advises GTCR in Healthcare Partnership with Michael Mulhern and Phil Macnabb to Form Epselon Global

Kirkland & Ellis advised leading private equity firm GTCR in its entrance into a partnership with Michael Mulhern and Phil Macnabb to form Epselon Global LLC. As part of the partnership, GTCR will invest in Epselon Global from GTCR Fund XIII. Mr. Mulhern will serve as executive chairman and Mr. Macnabb will serve as chief executive officer of Epselon Global, with each of them making substantial investments in the company alongside GTCR. The new company will focus on acquiring companies and assets as part of a strategy to build a market-leading healthcare business.

Read the GTCR press release 

The Kirkland team was led by transactional partners Sanford Perl and Michael Weed, and associate Neil Vohra; tax partner Polina Liberman; and litigation partner Jordan Heinz.